Ioannis Panagopoulos1, Kristin Andersen2, Ludmila Gorunova2, Marius Lund-Iversen3, Ingvild Lobmaier3, Sverre Heim2,4. 1. Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway; ioannis.panagopoulos@rr-research.no. 2. Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. 3. Department of Pathology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. 4. Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Abstract
BACKGROUND/AIM: Chimeras involving the high-mobility group AT-hook 2 gene (HMGA2 in 12q14.3) have been found in lipomas and other benign mesenchymal tumors. We report here a fusion of HMGA2 with the nuclear receptor co-repressor 2 gene (NCOR2 in 12q24.31) repeatedly found in tumors of bone and the first cytogenetic investigation of this fusion. MATERIALS AND METHODS: Six osteoclastic giant cell-rich tumors were investigated using G-banding, RNA sequencing, reverse transcription polymerase chain reaction, Sanger sequencing, and fluorescence in situ hybridization. RESULTS: Four tumors had structural chromosomal aberrations of 12q. The pathogenic variant c.103_104GG>AT (p.Gly35Met) in the H3.3 histone A gene was found in a tumor without 12q aberration. In-frame HMGA2-NCOR2 fusion transcripts were found in all tumors. In two cases, the presence of an HMGA2-NCOR2 fusion gene was confirmed by FISH on metaphase spreads. CONCLUSION: Our results demonstrate that a subset of osteoclastic giant cell-rich tumors of bone are characterized by an HMGA2-NCOR2 fusion gene.
BACKGROUND/AIM: Chimeras involving the high-mobility group AT-hook 2 gene (HMGA2 in 12q14.3) have been found in lipomas and other benign mesenchymal tumors. We report here a fusion of HMGA2 with the nuclear receptor co-repressor 2 gene (NCOR2 in 12q24.31) repeatedly found in tumors of bone and the first cytogenetic investigation of this fusion. MATERIALS AND METHODS: Six osteoclastic giant cell-rich tumors were investigated using G-banding, RNA sequencing, reverse transcription polymerase chain reaction, Sanger sequencing, and fluorescence in situ hybridization. RESULTS: Four tumors had structural chromosomal aberrations of 12q. The pathogenic variant c.103_104GG>AT (p.Gly35Met) in the H3.3 histone A gene was found in a tumor without 12q aberration. In-frame HMGA2-NCOR2 fusion transcripts were found in all tumors. In two cases, the presence of an HMGA2-NCOR2 fusion gene was confirmed by FISH on metaphase spreads. CONCLUSION: Our results demonstrate that a subset of osteoclastic giant cell-rich tumors of bone are characterized by an HMGA2-NCOR2 fusion gene.
Authors: S Wanschura; P Dal Cin; B Kazmierczak; S Bartnitzke; H Van den Berghe; J Bullerdiek Journal: Genes Chromosomes Cancer Date: 1997-04 Impact factor: 5.006
Authors: Andre M Oliveira; Antonio R Perez-Atayde; Paola Dal Cin; Mark C Gebhardt; Chang-Jie Chen; James R Neff; George D Demetri; Andrew E Rosenberg; Julia A Bridge; Jonathan A Fletcher Journal: Oncogene Date: 2005-05-12 Impact factor: 9.867
Authors: Andre M Oliveira; Antonio R Perez-Atayde; Carrie Y Inwards; Fabiola Medeiros; Victoria Derr; Bae-Li Hsi; Mark C Gebhardt; Andrew E Rosenberg; Jonathan A Fletcher Journal: Am J Pathol Date: 2004-11 Impact factor: 4.307
Authors: Andre M Oliveira; Bae-Li Hsi; Stanislawa Weremowicz; Andrew E Rosenberg; Paola Dal Cin; Nora Joseph; Julia A Bridge; Antonio R Perez-Atayde; Jonathan A Fletcher Journal: Cancer Res Date: 2004-03-15 Impact factor: 12.701